English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Es grande la expectativa que genera en todos los servicios de salud del mundo la rapida expansion del SARS-CoV2 (Coronavirus 2 del Sindrome Respiratorio Agudo y Grave), agente etiologico de la Enfermedad Infec-ciosa por Coronavirus del ano 2019, COVID-19 Por tratarse de una enfermedad emergente es poco lo que se conoce sobre su comportamiento en los humanos, lo que lleva a multiples interrogantes al momento de tomar decisiones en la practica clinica Hasta el momento, las estrategias para enfrentar esta pandemia se basan en la experiencia de los paises que han sido epicentro del brote infeccioso y en la evidencia recopilada durante el manejo de otros coronavirus en anos anteriores (SARS-CoV en el ano 2002 y MERS-CoV en 2012) La falta de informacion contundente y unificada ha dado lugar a especulaciones y a suposiciones, especialmente relacionadas con la atencion del COVID-19 en poblaciones consideradas de alto riesgo, como son los pacientes cronicamente inmunosuprimidos postrasplante A traves de esta revision narrativa de la literatura, mas alla de dar la opinion de los autores, se pretende organizar de manera juiciosa los documentos hasta el momento publicados, y responder, basados en datos reales, cinco de las preguntas mas importantes que surgen en el dia a dia durante el manejo de los pacientes trasplantadosThere is a high expectation generated by the rapid expansion of SARS-CoV2 (Severe Acute Respira-tory Syndrome related to Coronavirus 2), which is the etiological agent of the Coronavirus Infectious Disease 2019, COVID-19 As an emerging disease, little is known about its behavior in humans, which generates multiple questions when making decisions in clinical practice So far, the strategies to face this pandemic are based on the experience of the countries that have been the epicenter of the infectious outbreak and on the evidence collected during the management of other past coronavirus infections such as (SARS-CoV in 2002 and MERS-CoV in 2012) The lack of unified and robust information has given rise to speculation and assumptions primarily related to the care and management of COVID-19 in populations considered at high risk of infection, such as chronically immunosuppressed patients after transplantation Beyond giving the opinion from the authors, this narrative review tries to organize the documents published so far and to answer five of the most critical questions that arise every day during the management of transplant patients based on real data

Infección por SARS-CoV2 en pacientes con trasplante de órgano sólido: Cinco preguntas importantes.